GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 20 filers reported holding GALMED PHARMACEUTICALS LTD in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,026,000 | -24.4% | 363,700 | +24.2% | 0.09% | -26.2% |
| Q4 2017 | $2,679,000 | +4.5% | 292,847 | +4.4% | 0.12% | -20.3% |
| Q3 2017 | $2,564,000 | +101.3% | 280,500 | +36.5% | 0.15% | +115.5% |
| Q2 2017 | $1,274,000 | +26.8% | 205,500 | 0.0% | 0.07% | +20.3% |
| Q1 2017 | $1,005,000 | +39.4% | 205,500 | 0.0% | 0.06% | +5.4% |
| Q4 2016 | $721,000 | -20.9% | 205,500 | 0.0% | 0.06% | -32.5% |
| Q3 2016 | $912,000 | -1.2% | 205,500 | 0.0% | 0.08% | -10.8% |
| Q2 2016 | $923,000 | -8.9% | 205,500 | 0.0% | 0.09% | -2.1% |
| Q1 2016 | $1,013,000 | -35.2% | 205,500 | 0.0% | 0.10% | -43.8% |
| Q4 2015 | $1,564,000 | +2.4% | 205,500 | 0.0% | 0.17% | +21.6% |
| Q3 2015 | $1,527,000 | -24.4% | 205,500 | +2.3% | 0.14% | -26.1% |
| Q2 2015 | $2,020,000 | +6.3% | 200,788 | -0.5% | 0.19% | -32.1% |
| Q1 2015 | $1,901,000 | +62.3% | 201,848 | 0.0% | 0.28% | +48.9% |
| Q4 2014 | $1,171,000 | -32.5% | 201,848 | 0.0% | 0.19% | -27.6% |
| Q3 2014 | $1,736,000 | -11.7% | 201,848 | 0.0% | 0.26% | 0.0% |
| Q2 2014 | $1,966,000 | -14.3% | 201,848 | +0.9% | 0.26% | -1.5% |
| Q1 2014 | $2,294,000 | – | 200,000 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|